| ||||||||||||||
|
|
|||||||||||||


Departments of *Anesthesiology and
Radiology, Mayo Clinic College of Medicine, Rochester, Minnesota
Address correspondence and reprint requests to Eduardo N. Chini, MD, PhD, Department of Anesthesiology, Mayo Clinic, 200 First St. S.W., Rochester, MN 55905. Address e-mail to Chini.eduardo{at}mayo.edu
| Abstract |
|---|
|
|
|---|
IMPLICATIONS: Anesthesiologists are often asked to provide care for patients undergoing radiofrequency ablation of neoplastic lesions. It is important that they be aware of and be prepared to treat complications such as severe hypertension, tachycardia, and arrhythmias, which can occur during these procedures.
| Introduction |
|---|
|
|
|---|
| Case Report |
|---|
|
|
|---|
After placement of standard ASA monitors (pulse oximeter, ECG, and noninvasive arterial blood pressure cuff) and establishment of peripheral venous access, anesthesia was induced with IV lidocaine (40 mg), fentanyl (50 µg), and propofol (120 mg). Muscle relaxation was achieved with succinylcholine (120 mg). The patient was tracheally intubated without difficulty, and anesthesia was maintained with inhaled isoflurane (0.5%1.2%), nitrous oxide (70%), and oxygen (30%). Her arterial blood pressure was measured in the left upper extremity every 3 min. The patient remained hemodynamically stable throughout the induction of anesthesia and during RFA of the right renal mass. Shortly after initiation of ablation of the right adrenal mass, severe hypertension was noted (249/140 mm Hg). Concomitantly, her ECG showed a narrow complex tachycardia (140 bpm) with frequent multifocal premature ventricular contractions (Fig. 1). Ablation was suspended, and her increased arterial blood pressure and heart rate were treated with incremental doses of esmolol (100 mg total; 1.25 mg/kg). Sodium nitroprusside was not immediately available during this hypertensive episode. Her heart rate and rhythm and her blood pressure returned to baseline levels 5 min after esmolol administration and suspension of ablation. Because of the curative nature of the procedure, the final ablation attempt of the adrenal mass commenced and was associated with a similar hypertensive response that was successfully treated with esmolol (50 mg). The procedure concluded, and the patient was tracheally extubated and taken to the postanesthesia care unit. In the postanesthesia care unit, the patient remained hemodynamically stable. There was no evidence of neurologic, cardiac, or pulmonary complications during recovery or on subsequent follow-up.
|
| Discussion |
|---|
|
|
|---|
Mayo-Smith and Dupuy (8) reported no intraoperative complications in 12 patients who underwent 13 RFA procedures of the adrenal gland. However, RFA can cause severe hemodynamic consequences. Onik et al. (7) described life-threatening hypertensive crises in two patients undergoing hepatic RFA. Onik et al. suggested that ablation of tumors located in the posterior right lobe of the liver can cause unintended heating of and injury to the adrenal gland, leading to catecholamine release and subsequent hemodynamic effects. One of the patients in the report by Onik et al. had catecholamine concentrations measured during RFA that were 10 times larger than normal.
Open and laparoscopic adrenalectomy for nonsecreting adrenal tumors is rarely associated with severe intraoperative hypertension. Ligation of the adrenal vein is typically performed after surgical exposure of the adrenal gland is achieved. Ligation of the adrenal vein will prevent the release of catecholamines into the systemic circulation should injury to normal adrenal tissue occur. In contrast, ligation of the adrenal vein is not performed during RFA of adrenal tumors.
The hypertensive crisis in our patient was likely related to injury of normal adrenal tissue in or near the adrenal mass being ablated, causing the release of catecholamines into the circulation. Catecholamine surge can lead to tachycardia, cardiac arrhythmias, and rapid increases in afterload, resulting in cardiac ischemia, diastolic dysfunction, ventricular failure, and pulmonary edema. In addition to cardiac damage, acute hypertensive crisis can lead to central nervous system sequelae such as hemorrhagic stroke (9). The optimal treatment of catecholamine-induced hypertensive crises during anesthesia is not known. According to Groudine et al. (9), direct-acting vasodilators may be the treatment of choice. Long-acting ß-blockers can potentially precipitate cardiac failure during this situation and should be avoided. Esmolol may be a good choice for treating tachycardia that develops during catecholamine surge. The effectiveness of a preoperative regimen consisting of an
1-adrenergic antagonist followed by a ß1-adrenergic antagonist for preventing the sequelae of catecholamine surge in patients with metastatic nonsecreting adrenal masses undergoing RFA is not known.
In conclusion, experience with RFA of adrenal tumors is limited. The sudden severe hypertension, tachycardia, and ventricular irritability seen in our patient were probably caused by massive catecholamine release into the circulation as a result of heating and subsequent injury to normal adrenal tissue. The adrenal vein is not separated from the systemic circulation during RFA of adrenal masses, thus allowing the catecholamine surge to reach the systemic circulation. Clear information identifying whether adrenal masses targeted for RFA contain functional adrenal tissue is frequently not available. We suggest direct measurement of arterial blood pressure in addition to routine ASA monitoring when providing anesthetic care for patients scheduled for RFA of adrenal lesions. Direct-acting vasodilators and short-acting ß1-adrenergic antagonists and a means to administer these medications (infusion pumps) should be readily available when delivering anesthesia in remote locations. Identifying normal functional adrenal tissue in or around adrenal masses to be ablated should increase awareness of the potential for catecholamine surge during RFA. Careful planning and discussion with the radiologist about the possibility for catecholamine surge should help to reduce the incidence and severity of these complications.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
K. Yamakado, H. Anai, H. Takaki, H. Sakaguchi, T. Tanaka, K. Kichikawa, and K. Takeda Adrenal Metastasis From Hepatocellular Carcinoma: Radiofrequency Ablation Combined With Adrenal Arterial Chemoembolization in Six Patients Am. J. Roentgenol., June 1, 2009; 192(6): W300 - W305. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Y. Xiao, J.-L. Tian, J.-K. Li, L. Yang, and J.-S. Zhang CT-Guided Percutaneous Chemical Ablation of Adrenal Neoplasms Am. J. Roentgenol., January 1, 2008; 190(1): 105 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Elliott, T. B. Curry, T. D. Atwell, M. J. Brown, and S. H. Rose Lung isolation, one-lung ventilation, and continuous positive airway pressure with air for radiofrequency ablation of neoplastic pulmonary lesions. Anesth. Analg., August 1, 2006; 103(2): 463 - 4, table of contents. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|